HSLotsof at aol.com HSLotsof at aol.com
Sat Jul 20 22:54:18 EDT 2002

Barbara Harris 
Children Requiring A Caring Kommunity's 
"Project Prevention" 
P.O. Box 74 
Stanton, CA 90680 

Dear Ms. Harris: 

We are writing to express our strong objections to your distribution of 
highly misleading and completely inaccurate information regarding pregnant 
women and methadone treatment. In a letter date February 22, 2002, you state, 
in part: 

"We are currently working with several methadone clinics that make our offer 
known, and available, to the women and men who come through their program. 
I'm sure one thing most can agree on is that it is important for those using 
methadone or other drugs to refrain from getting pregnant." 

We most certainly do not agree. Your statement, suggesting that it is 
dangerous for a woman who is receiving clinically prescribed methadone 
treatment to become pregnant, is simply wrong. Methadone is a highly 
effective treatment for all opiate dependent patients and, most specifically, 
for women - both before and after they may become pregnant. In fact, methadone
 treatment during pregnancy has not been associated with congenital 
abnormalities or fetal demise. In those cases where neonatal withdrawal 
symptoms occur (and they frequently do not), these symptoms can be treated 
readily, with no evidence of any adverse impact on physical or cognitive 
development. In short, there is simply no medical basis for your suggestion 
that methadone patients should "refrain from getting pregnant." 

For over 30 years, in countries throughout the world, methadone maintenance 
treatment (MMT) has been shown to substantially reduce illegal opiate use and 
the crime, illness, suffering, and death with which it is associated. The 
benefits have been shown to accrue, not only to the individual patient, but 
to his/her family and the community, as well. The most credible and objective 
governmental and non-governmental organizations in America and abroad have 
recognized these positive results with MMT. For example, the US Department of 
Health and Human Services joins the scientific community in recognizing that 
MMT greatly benefits the patients as well as the general community. It is 
specifically recommended for pregnant and breast-feeding patients, which 
further demonstrates the strong medical consensus supporting methadone 
treatment, both in general and during pregnancy. 

Unfortunately, despite methadone treatment's many benefits, it is available 
to fewer than 20% of the people who most need it. Women, in particular, face 
numerous barriers to obtaining this important medical intervention. Your 
letter and activities, which spread false information and stigmatize current 
and future mothers who receive this treatment, will make it even more 
difficult for women who need methadone treatment to receive it. 

We therefore urge you to withdraw this letter immediately and to advise each 
of those individuals and clinics who received it that it was based on 
misinformation. Furthermore, it is essential that you publicly repudiate the 
inaccurate message you conveyed on your organization's website and in other 
public and media context. Not to do so would be irresponsible and a great 
disservice to those whose interests you claim to have at heart. 



1. Lynn Singer, Ph.D, Professor of Pediatrics and Psychiatry, Case Western 
Reserve University, School of Medicine 
2. Stephen Kandall, MD, Retired Professor of Pediatrics, Albert Einstein 
College of Medicine 
3. Daniel Neuspiel, MD, MPH, Associate Chairman of Pediatrics, Beth Israel 
Medical Center 
4. Robert Newman, MD, Director, Baron Edmond de Rothschild Chemical 
Dependency Institute of Beth Israel Medical Center 
5. Barry Lester, Ph.D., Director, Infant Development Center, Women and 
Infants’ Hospital 
6. Mary Faith Marshall, Ph.D., Professor of Medicine and Bioethics, Kansas 
University Medical Center 
7. Maryann Amodeo, Ph.D., Professor, Boston University School of Social Work, 
Alcohol and Drug Institute for Policy, Research and Training 
8. Denise Paone, Ph.D., Evaluation and Training Consultant, Former Assistant 
Director of Research, Chemical Dependency Institute, Beth Israel Medical 
9. John J. Botti, MD, Director, Maternal Fetal Medicine, Penn State Hershey 
Medical Center 
10. Mary Mahowald, Ph.D., Professor, Dept. of OB/GYN, University of Chicago 
11. Machelle Allen, MD, Assistant Professor, Department of OB/GYN, NYU School 
of Medicine 
12. Wendy Chavkin, MD, MPH, Clinical Professor of Public Health and OB/GYN, 
Columbia University, Mailman School of Public Health 
13. Marjorie Greenfield MD, Associate Professor of OB/GYN, University 
Hospitals of Cleveland, Case Western Reserve University School of Medicine 
14. Hytham Imseis, MD, Mountain Area Health Education Center, Dept. of OB/GYN 
15. Dona Upson, MD, Associate Professor of Medicine, University of New Mexico 
16. Mack Lipkin, Jr., MD, Director of Primary Care, NYU School of Medicine 
17. Ernest Drucker, Ph.D., Professor of Epidemiology and Social Medicine, 
Montefiore Medical Center/Albert Einstein School of Medicine 
18. Angela R. Holder, LLM, Professor of the Practice of Medical Ethics, 
Center for the Study of Medical Ethics and Humanities, Duke University 
Medical Center 
19. Sydney L. Hans, Ph.D., Research Associate Professor, Department of 
Psychiatry, University of Chicago 
20. Craig Reinarman, Ph.D., Chair and Professor, Dept. of Sociology, UC Santa 
21. Rachel Roth, Ph.D., Assistant Professor, Washington University 
22. Monica J. Casper, Ph.D., Associate Professor of Sociology, UC Santa Cruz 
23. Anthony R. Kovner, Ph.D., Professor of Health Policy and Management, 
24. Susan L. Adams, Ph.D., RN, Associate Professor of Nursing, Women’s 
Health Nurse Practitioner, Perinatal Addiction, Dominican University of 
25. Nina Peskoe Peyser, Former Executive Director of the Chemical Dependency 
Institute at Beth Israel Medical Center 
26. Holly Catania, Baron Edmond de Rothschild Chemical Dependency Institute 
of Beth Israel Medical Center 
27. Nancy D. Campbell, Ph.D., Assistant Professor, Rensselaer Polytechnic 
28. Jerome Richardson, Assistant Professor, University of Illinois at Chicago 
29. Karyn L. Pomerantz, MLS, MPH, GW School of Public Health & Health 
30. Janet Lynne Golden, Ph.D., Associate Professor, Rutgers University 
31. Cynthia Daniels, Ph.D., Associate Professor, Rutgers University 
32. Drew Humphries, Ph.D., Department of Sociology, Anthropology and Criminal 
Rutgers University 
33. Elizabeth M. Armstong, Ph.D., Assistant Professor, Princeton University 
34. Jael Silliman, Ed.D., Associate Professor, University of Iowa 
35. Jeanne Flavin, Ph.D., Associate Professor, Fordham University 
36. Victor J. Bernstein, Ph.D., Associate Professor, University of Chicago 
37. Grace Chang, Ph.D., Evergreen State College 
38. Mario A. Caro, Ph.D. Candidate, Professor, Evergreen State College 
39. Phillip Coffin, MIA, Project Director, Center for Urban Epidemiologic 
Studies, New York Academy of Medicine 
40. Sheigla Murphy, Ph.D., Institute for Scientific Analysis 
41. Leslie D. McCrory, Clinical Supervisor, Health Partners 
42. Ann D. Brown, CNM, MSN, Dept. of OB/GYN, Mountain Area Health Education 
43. Shelley Galvin, MA, Research & Grants Coordinator, Dept. of OB/GYN, 
Mountain Area Health Education Center 
44. Susan Shinn, RNC, Women’s Health, Mountain Area Health Education 
45. Melissa McClure, Medical Records Coordinator, Mountain Area Perinatal 
Substance Abuse Program 
46. Cheryl Timbs, Clinical Supervisor, Mountain Area Perinatal Substance 
Abuse Program 
47. Elizabeth Finger, LWW, Director of Behavior Medicine, Mountain Area 
Health Education Center 
48. Terry Sutton, Program Assistant, Mountain Area Health Education Center 
49. Jean Cassidy, Dept. of OB/GYN, Mountain Area Health Education Center 
50. Steve Allison, Certified Clinical Addiction Specialist, Mountain Area 
Health Education Center 
51. Gregory McCoy, Mountain Area Perinatal Substance Abuse Program 
52. Michael Eisenberg, MD, MPH, President, ASPIRE 
53. Luciano Colonna, Executive Director, Harm Reduction Project 
54. Michael R. Aldrich, Ph.D 
55. Ivan Zimmerman, J.D. 
56. Rickie Solinger, Ph.D., Historian 
57. National Women's Health Network 
58. National Black Women’s Health Project 
59. National Association for Public Health Policy Council on Illicit Drugs 
60. Institute for Health and Recovery 
61. Advocates for Recovery through Medicine (ARM) 
62. Advocates for Recovery through Medicine (ARM) of Arkansas & Oklahoma 
63. Advocates for Recovery through Medicine (ARM) of DC 
64. Connecticut Women’s Consortium 
65. Casa Segura 
66. Lower East Side Harm Reduction Center 
67. Addiction Treatment Watchdog 
68. CAP Quality Care Methadone Clinic 
69. Virginia Alliance of Methadone Advocates 
70. Vermont Harm Reduction Coalition 
71. San Francisco AIDS Foundation HIV Prevention Project 
72. AIDS Project New Haven 
73. HIV Law Project 
75. Drug Policy Alliance 
76. Urban Justice Center 
77. Criminal Justice Policy Institute 
78. Center for Human Rights Education 
79. Family Watch 
80. Committee on Women, Population, and the Environment 
81. Cambridge Cares About AIDS 
82. California Coalition for Women Prisoners 
83. Legal Services for Prisoners With Children 
84. NORML Foundation 
85. Common Sense for Drug Policy 
86. Drug Policy Forum of Hawaii 
87. ReconsiDer 
88. Communities Against Rape and Abuse 
89. Mikki Norris, Human Rights and the Drug War 
90. Alice Diorio, President, Vermont Harm Reduction Coalition 
91. Kevin Zeese, Executive Director, Common Sense for Drug Policy 
92. Donna M. Shea, Legal Director, NORML 
93. Mark Beresky, Secretary/Treasurer, Vermont Harm Reduction Coalition 
94. Marc Shinderman, MD, CAP Quality Care Methadone Clinic 
95. Cassie Pierson, Staff Attorney, Legal Services for Prisoners with 
96. Monique Tula, Director of Harm Reduction Services, Cambridge Cares About 
97. Eliza Wheeler, Needle Exchange Program Coordinator, Cambridge Cares About 
98. Robin Clark-Smith, AIDS Program, Bridgeport Health Department 
99. Terri Bogage, Institute for Health and Recovery 
100. Syd Lindsley, Committee on Women, Population, and the Environment 
101. Jacqueline Robarge, Power Inside 
102. Stephanie Manfre, Children’s Case Manager, Riley Center 
103. Ann Beck, Riley Center 
104. Jennifer Grant, Director, Riley Center 
105. Teresa Martyny, Riley Center 
106. Kylie Chow, Brennan House 
107. JoAnn Yang, Riley Center 
108. Michelle Rivera, Riley Center 
109. Carolina Alaniz, Riley Center 
110. Idoia Irastorza, Riley Center 
111. Megan Koroshetz, Riley Center 
112. Stacy Benedict, Riley Center 
113. Liliana Diaz, San Francisco Department of Public Health 
114. Ellenie Tuazon, San Francisco Department of Public Health 
115. Elba Warner, San Francisco Department of Public Health 
116. Ebone Colbert, Communities Against Rape and Abuse 
117. Theryn Kigvamasud’Vashti, Communities Against Rape and Abuse 
118. Alisa Bierria, Program Coordinator, Communities Against Rape and Abuse 
119. Shane Felles 
120. Brion Roberts 
121. Susan Yanow, Director, Abortion Access Project 
122. Shiela VanDerveer, Development Director, NARAL – NH 
123. NOW Legal Defense and Education Fund 
124. Marsha Rosenbaum, Ph.D., Director, Safety First Project, Drug Policy 
125. Ann M. Boyer, MD, MS, Mt. Sinai Medical Center 
126. Nancy Mamis-King, Associate Executive Director, Neighborhood Youth & 
Family Services 
127. Maureen Denman, Atlantic Health System 
128. Shelly Carter, Health Educator, New Mexico Prenatal Care Network, 
University of New Mexico 
129. National Council on Alcoholism & Drug Dependence 
130. Gloria Knighton 
131. Virginia Nurses Society on Addictions 
132. National Alliance of Methadone Advocates 
133. National Advocates for Pregnant Women

More information about the Ibogaine mailing list